Olon USA and Olon SpA will participate in CPhI Americas 2026, taking place June 2–4, 2026, at the Pennsylvania Convention Center in Philadelphia. The event brings together pharmaceutical and biotech companies from North America, Central America, and South America, creating a focused environment for partnerships across the region.
A Targeted Forum for Pharmaceutical Development and Manufacturing
CPhI Americas provides direct access to companies actively advancing small-molecule programs. The event concentrates decision-makers, technical teams, and sourcing leaders in one location. This structure enables efficient evaluation of development and manufacturing partners.
Olon USA uses this setting to engage both existing clients and new collaborators. Meetings are structured to address active programs, evaluate technical requirements, and define next steps without delay.
Full-Scope CDMO Capabilities on Display
Olon USA will present expanded capabilities across the full development lifecycle. The organization supports programs from early preclinical stages through commercial manufacturing.
Recent investments have strengthened operations in Ohio, including:
- Expanded capacity for early-stage development, beginning at the milligram scale following target identification
- GMP manufacturing capabilities, scaling to approximately 175 kg for commercial production
- Dedicated high-potency (HPAPI) suite available for rapid project onboarding
- Enhanced quality systems and environmental, health, and safety infrastructure
These capabilities enable continuity from development through commercialization within a single network.
Support Beyond Manufacturing
Olon USA supports more than process development and API production. Services include custom synthesis of impurity standards and reference materials, along with analytical qualification. These capabilities support regulatory readiness and ongoing quality control, even for products manufactured outside the Olon network.
Integrated Global and U.S. Operations
The Americas-focused audience aligns with Olon USA’s core customer base. At the same time, the company connects these programs to a broader global manufacturing network. This structure supports both regional supply strategies and international scale-up.
In addition to CDMO services, Olon’s generics portfolio team will be present to discuss available APIs and supply opportunities for the U.S. market.
Meet the Olon USA Team in Philadelphia
Olon USA will bring a full business development and technical team to CPhI Americas 2026. Attendees can expect direct access to decision-makers with the authority to initiate and advance projects.
An exclusive, invitation-only event will also take place during the conference. This provides a more focused setting for in-depth discussions. Interested participants can request details in advance.
Engage Early to Accelerate Your Program
Companies developing small molecules at any stage should plan to meet with the Olon Group during CPhI Americas 2026 at stand 731. Early engagement enables faster project initiation, clearer technical alignment, and reduced time to scale.
Olon USA is prepared to evaluate new opportunities, define development strategies, and begin work without delay. Connect with the team ahead of the event or schedule a meeting in Philadelphia to move your project forward.